DNA Stock Overview – The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
NYSE:DNA

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 14, 2024

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$DNA N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
Ginkgo Bioworks Holdings, Inc. Loading... Loading...
Sector Name Loading... N/A

Related

OCEAOcean Biomedical, Inc.-7.1%
ENVBEnveric Biosciences, Inc.-4.2%
HEPAHepion Pharmaceuticals, Inc.2.9%
ELEVElevation Oncology, Inc.-7.2%
AVROAVROBIO, Inc.-2.7%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2001FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue98M54M77M314M478M251M
Growth Rate--44.9%41.5%309.4%52.2%-47.4%
EBITDA-220M-81M-108M-1,878M-2,180M-601M
EBITDA Margin-223.5%-149.6%-140.3%-598.3%-456.4%-238.9%
Net Income0M-120M-127M-1,837M-2,106M-893M
NI Margin0.0%-221.2%-165.3%-585.2%-440.9%-355.1%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.